Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,098,716 papers from all fields of science
Search
Sign In
Create Free Account
AS02A
An oil-water emulsion comprised of QS21 and 3D-MPL used as a vaccine adjuvant to improve T-helper cells and antibody response.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
SB AS-2
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
A Shot to Change the World: An Analysis of Process and Partnership in U.S. Military Vaccine Research
Sarah E. McNair
2015
Corpus ID: 154334320
2012
2012
Induction of Strong HIV-1–Specific CD4+ T-Cell Responses Using an HIV-1 gp120/NefTat Vaccine Adjuvanted With AS02A in Antiretroviral-Treated HIV-1–Infected Individuals
M. Lichterfeld
,
R. Gandhi
,
+18 authors
M. Altfeld
Journal of Acquired Immune Deficiency Syndromes
2012
Corpus ID: 11722531
BackgroundInduction of HIV-1–specific CD4+ T-cell responses by therapeutic vaccination represents an attractive intervention to…
Expand
Review
2012
Review
2012
Progress and Challenges towards the Development of Malaria Vaccines
K. Tetteh
,
S. Polley
BioDrugs
2012
Corpus ID: 25929907
The promise afforded by attenuated sporozoite vaccines in the 1970s led many researchers to believe that an efficacious malaria…
Expand
2011
2011
Time to get serious about HIV antiretroviral resistance.
E. Wood
,
J. Montaner
Lancet. Infectious Diseases (Print)
2011
Corpus ID: 5209165
2009
2009
Evaluation of the safety and immunogenicity of Plasmodium falciparum apical membrane antigen 1, merozoite surface protein 1 or RTS,S vaccines with adjuvant system AS02A administered alone or…
S. Pichyangkul
,
P. Tongtawe
,
+17 authors
R. Miller
Vaccine
2009
Corpus ID: 31827215
2008
2008
Safety of the RTS,S/AS02A malaria vaccine in Mozambican children during a Phase IIb trial.
J. Sacarlal
,
J. Aponte
,
+16 authors
P. L. Alonso
Vaccine
2008
Corpus ID: 21214497
2006
2006
Cutaneous delayed-type hypersensitivity (DTH) in a multi-formulation comparator trial of the anti-falciparum malaria vaccine candidate RTS,S in rhesus macaques.
V. A. Stewart
,
D. Walsh
,
+7 authors
D. Heppner
Vaccine
2006
Corpus ID: 25819099
Highly Cited
2006
Highly Cited
2006
Safety and immunogenicity of the RTS,S/AS02A candidate malaria vaccine in children aged 1–4 in Mozambique
E. Macete
,
E. Macete
,
+25 authors
P. L. Alonso
Tropical medicine & international health
2006
Corpus ID: 24060661
Background The development of a malaria vaccine remains a public health priority for sub‐Saharan Africa. RTS,S/AS02A candidate…
Expand
Review
2006
Review
2006
RTS,S/AS02A for malaria
K. Bojang
Expert Review of Vaccines
2006
Corpus ID: 24263623
Malaria prevention and treatment is becoming increasingly difficult as drug-resistant strains of parasites spread globally and…
Expand
Review
2006
Review
2006
Malaria: deploying a candidate vaccine (RTS,S/AS02A) for an old scourge of humankind.
P. Alonso
International Microbiology
2006
Corpus ID: 15532118
Malaria is an infectious disease caused by the protist Plasmodium spp. and it currently kills more than one million people…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE